StockStory Highlights MSA Safety and Limbach as Cash-Producing Stocks, Flags Bristol-Myers Squibb Headwinds

StockStory··Read original
2▲2 ▼1Impact / 5
Summary · why it matters

StockStory identifies MSA Safety and Limbach as cash-producing stocks worth investigating, while warning that Bristol-Myers Squibb faces headwinds. Bristol-Myers Squibb's trailing 12-month free cash flow margin stands at 24.6%, but the company has seen annual revenue growth of only 2.6% over the last five years and an estimated sales decline of 5.5% for the next 12 months, with its adjusted operating margin falling by 10.4 percentage points. MSA Safety, with a free cash flow margin of 16.1%, has grown annual earnings per share by 14.1% over five years, boosted by share buybacks, and its free cash flow margin expanded by 6.6 percentage points. Limbach, at a 5.2% free cash flow margin, delivered 12.6% annual revenue growth over the last two years and 29.1% annual earnings per share growth, while its free cash flow margin widened by 7.3 percentage points over five years.

Impact on assets 3

Biotech & Genomic Medicine▼ · 1 stocks
Bristol-Myers Squibb Company
BMY
▼ NegativeCapitalrelevance

Article highlights declining revenue growth, falling adjusted operating margin, and sales decline forecast.

Industrials▲ · 1 stocks
Limbach Holdings Inc
LMB
▲ PositiveCapitalrelevance

Article notes strong revenue and EPS growth, and expanding free cash flow margin.

Defense & Geopolitical Fragmentation▲ · 1 stocks
MSA Safety
MSA
▲ PositiveCapitalrelevance

Article highlights strong EPS growth, share buybacks, and expanding free cash flow margin.

© 2026 MarketIVNews